S 1157 United States Senate · 119th Congress

Women and Lung Cancer Research and Preventive Services Act of 2025

This bill mandates an interagency review by the Health and Human Services, Defense, and Veterans Affairs secretaries to accelerate research on lung cancer in women and underserved populations (including those eligible for screening per USPSTF guidelines). It requires evaluating existing research gaps, identifying collaborative opportunities for innovative studies (like environmental/genomic factors), developing a national screening strategy, and creating public education campaigns focused on early detection. The review must produce a comprehensive report to Congress within two years of enactment. The bill directly affects women and underserved groups at higher risk for lung cancer by targeting research, screening access, and awareness.
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2025
Committee Review
Jan 2026
Senate Passage
Jun 2026
House Passage
President
Introduced Mar 26, 2025 Last action Jun 9, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced in Senate Engrossed in Senate · 10 edits · Jun 8, 2026
MAJOR
The engrossed version narrows the bill's focus from a broad interagency review covering lung cancer research in women and underserved populations, access to preventive services, and public awareness campaigns to a more targeted effort to improve lung cancer prevention and treatment specifically in women and populations with few known risk factors. The action required of HHS shifts from identifying opportunities for accelerated research to actually reviewing and updating Federal programs and strategic plans. Report requirements are expanded to require specific findings, descriptions of changes made, and identification of barriers to implementation.
SCOPE

The bill's focus narrowed from covering lung cancer in women AND underserved populations meeting USPSTF screening criteria, access to preventive services, and public awareness campaigns, to focusing on improving lung cancer prevention and treatment in women and populations with few known risk factors.

Removed explicit focus on 'underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force' as a distinct target group.

Added 'populations with few known risk factors' as a target group alongside women, which is a different framing than the previous 'underserved populations' language.

REQUIREMENT

HHS is now required to review and update Federal programs, activities, and strategic plans (not just identify opportunities for accelerated research). The action is more prescriptive: 'review and, as necessary and appropriate, update' rather than 'evaluate the status of, and identify opportunities for the acceleration of.'

Research opportunities now specifically include evaluation of environmental and genomic factors related to lung cancer etiology in women (moved from a separate item into the first research opportunity), and advances in 'technology and interventions, including biomarker testing' replacing the prior focus on 'imaging technology and techniques.'

Removed the specific call for development of a 'national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations.'

Removed the specific call for development of a 'national public education and awareness campaign' on lung cancer in women/underserved populations and early detection.

Added requirement to review current public health strategies and consider alternative evidence-based strategies related to lung cancer screening and diagnosis, including an assessment of the need for additional public awareness and education.

ENFORCEMENT

The 2-year report now must include three specific components: a summary of research findings and knowledge gaps, a description of changes already made to Federal programs based on findings, and any additional recommended changes along with statutory or other barriers impeding implementation. Previously it was simply a general report on the review.

TECHNICAL

Report recipients changed from generic 'to Congress' to specific committees: Senate HELP, Senate Appropriations, House Energy and Commerce, and House Appropriations.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
3
Jun 8, 2026
Upper · Passed
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S2669-2670; text: CR S2669-2670)
upper
Jun 8, 2026
Upper · Passed
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
upper
Jan 28, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
upper
Jan 15, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
upper
Mar 26, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Mar 26, 2025
Introduced
Introduced in Senate
upper
1 primary · 7 co-sponsors

Sponsors